Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV   IE00B68SQD29

COVIDIEN PLC (COV)

22
Delayed Quote. Delayed Nyse - 11/24 12:21:00 pm
98.87 USD   +0.44%
3d ago COVIDIEN : Announces Mailing of Definitive Joint Proxy Statement/Prospectus
3d agoDJCovidien Files 8K - Regulation FD
3d ago SEC director with big stock holdings stirs debate
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/18/2014 11/19/2014 11/20/2014 11/21/2014 11/24/2014 Date
98.09(c) 97.5(c) 97.91(c) 98.44(c) 98.87 Last
4 725 549 2 952 786 3 145 175 3 824 559 877 906 Volume
+3.68% -0.60% +0.42% +0.54% +0.44% Change
More quotes
Company
Covidien Plc engages in the development, manufacture and sale of healthcare products for use in clinical and home settings.It operates through three segments: Medical Devices, Pharmaceuticals and Medical Supplies.The Medical Devices segment includes the development, manufacture and sale of... 
Surperformance© rating of Covidien plc
Trading Rating : Investor Rating :
More about the company
Chart COVIDIEN PLC
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 11 030 M
EBIT 2015 2 535 M
Net income 2015 1 950 M
Debt 2015 1 611 M
Yield 2015 1,41%
Sales 2016 11 490 M
EBIT 2016 2 745 M
Net income 2016 2 140 M
Debt 2016 333 M
Yield 2016 1,52%
PER 2015 22,83
PER 2016 20,62
EV / Sales 2015 4,18x
EV / Sales 2016 3,90x
Capitalization 44 471 M
More Financials
Latest news on COVIDIEN PLC
3d ago COVIDIEN : Announces Mailing of Definitive Joint Proxy Statement/Prospectus
3d agoDJCovidien Files 8K - Regulation FD
3d ago SEC director with big stock holdings stirs debate
4d ago COVIDIEN : Achieves CE Mark for the Nellcor™ Bedside SpO2 Patient Monitori..
5d ago COVIDIEN : Announcement under Irish Takeover Rules Relevant Securities in Issue ..
5d agoDJMallinckrodt Sales Surge on Acquisitions in Specialty Pharma Segment
6d agoDJMedtronic Sales Rise, Backs Covidien Deal -- 2nd Update
6d ago Medtronic profit meets expectations; Covidien deal on track
6d agoDJMedtronic Sales Drop in Core Pacemaker Business -- Update
6d agoDJMedtronic Revenue Grows 4.1%, Backs Commitment to Covidien Deal
7d agoDJCovidien Files 8K - Other Events
7d agoDJMedtronic Profit, Sales Seen Rising in 2Q -- Earnings Preview
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF